Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × Vorinostat × Clear all

NCT01045538 2020-01-07

Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms